FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:1555-1564 October 9, 2008 Number 15 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Supplementary Material Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Young infants and pregnant women are at increased risk for serious consequences of influenza infection. Inactivated influenza vaccine is recommended for pregnant women but is not licensed for infants younger than 6 months of age. We assessed the clinical effectiveness of inactivated influenza vaccine administered during pregnancy in Bangladesh.

Methods In this randomized study, we assigned 340 mothers to receive either inactivated influenza vaccine (influenza-vaccine group) or the 23-valent pneumococcal polysaccharide vaccine (control group). Mothers were interviewed weekly to assess illnesses until 24 weeks after birth. Subjects with febrile respiratory illness were assessed clinically, and ill infants were tested for influenza antigens. We estimated the incidence of illness, incidence rate ratios, and vaccine effectiveness.

Results Mothers and infants were observed from August 2004 through December 2005. Among infants of mothers who received influenza vaccine, there were fewer cases of laboratory-confirmed influenza than among infants in the control group (6 cases and 16 cases, respectively), with a vaccine effectiveness of 63% (95% confidence interval [CI], 5 to 85). Respiratory illness with fever occurred in 110 infants in the influenza-vaccine group and 153 infants in the control group, with a vaccine effectiveness of 29% (95% CI, 7 to 46). Among the mothers, there was a reduction in the rate of respiratory illness with fever of 36% (95% CI, 4 to 57).

Conclusions Inactivated influenza vaccine reduced proven influenza illness by 63% in infants up to 6 months of age and averted approximately a third of all febrile respiratory illnesses in mothers and young infants. Maternal influenza immunization is a strategy with substantial benefits for both mothers and infants. (ClinicalTrials.gov number, NCT00142389 [ClinicalTrials.gov] .)

Source Information

From the International Centre for Diarrheal Disease Research, Dhaka, Bangladesh (K.Z., E.R., S.E.A., M.R., R.R., N.S.S., R.F.B.); and the Bloomberg School of Public Health (E.W., S.B.O., M.C.S.), Institute for Vaccine Safety (S.B.O.), and Department of Pediatrics, School of Medicine (M.C.S.) — all at Johns Hopkins University, Baltimore.

This article (10.1056/NEJMoa0708630) was published at www.nejm.org on September 17, 2008.

Address reprint requests to Dr. Steinhoff at the Children's Global Health Center, Cincinnati Children's Hospital, 3333 Burnet Ave., MLC 2048, Cincinnati, OH 45229, or at m.steinhoff{at}gmail.com.

Full Text of this Article

Related Letters:

Effectiveness of Maternal Influenza Immunization
Tandon S. S., Omer S. B., Zaman K., Steinhoff M. C.
Extract | Full Text | PDF  
N Engl J Med 2009; 360:537-538, Jan 29, 2009. Correspondence

This article has been cited by other articles:

• (2009). Receipt of Influenza Vaccine During Pregnancy Among Women With Live Births--Georgia and Rhode Island, 2004-2007. JAMA 302: 1964-1966 [Full Text]  
• Francis, J. P., Richmond, P. C., Pomat, W. S., Michael, A., Keno, H., Phuanukoonnon, S., Nelson, J. B., Whinnen, M., Heinrich, T., Smith, W.-A., Prescott, S. L., Holt, P. G., Siba, P. M., Lehmann, D., van den Biggelaar, A. H. J. (2009). Maternal Antibodies to Pneumolysin but Not to Pneumococcal Surface Protein A Delay Early Pneumococcal Carriage in High-Risk Papua New Guinean Infants. CVI 16: 1633-1638 [Abstract] [Full Text]  
• Rappuoli, R., Del Giudice, G., Nabel, G. J., Osterhaus, A. D. M. E., Robinson, R., Salisbury, D., Stohr, K., Treanor, J. J. (2009). Rethinking Influenza. Science 326: 50-50 [Abstract] [Full Text]  
• Rasmussen, S. A., Jamieson, D. J., MacFarlane, K., Cragan, J. D., Williams, J., Henderson, Z. (2009). Pandemic Influenza and Pregnant Women: Summary of a Meeting of Experts. AJPH 99: S248-S254 [Abstract] [Full Text]  
• Glezen, W. P. (2009). Influenza. JAMA 301: 1175-1177 [Full Text]  
• Tandon, S. S., Omer, S. B., Zaman, K., Steinhoff, M. C. (2009). Effectiveness of Maternal Influenza Immunization. NEJM 360: 537-538 [Full Text]  
• Shane, A. L. (2009). Effectiveness of Maternal Influenza Immunization in Mothers and Infants. AAP Grand Rounds 21: 1-1 [Full Text]  
• Glezen, W. P. (2008). Prevention and Treatment of Seasonal Influenza. NEJM 359: 2579-2585 [Full Text]  
• MOSSAD, S. B. (2008). 2008-2009 Influenza update: A better vaccine match. Cleveland Clinic Journal of Medicine 75: 865-870 [Abstract] [Full Text]